- Home
- POAI vs EVAX Comparison
POAI vs EVAX Comparison
Compare POAI & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- EVAX
- Stock Information
- Founded
- POAI 2002
- EVAX 2008
- Country
- POAI United States
- EVAX Denmark
- Employees
- POAI N/A
- EVAX N/A
- Industry
- POAI Industrial Specialties
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- POAI Health Care
- EVAX Health Care
- Exchange
- POAI Nasdaq
- EVAX Nasdaq
- Market Cap
- POAI 7.8M
- EVAX 17.8M
- IPO Year
- POAI N/A
- EVAX 2021
- Fundamental
- Price
- POAI $0.93
- EVAX $2.90
- Analyst Decision
- POAI Hold
- EVAX Strong Buy
- Analyst Count
- POAI 1
- EVAX 2
- Target Price
- POAI N/A
- EVAX $10.00
- AVG Volume (30 Days)
- POAI 122.8K
- EVAX 89.0K
- Earning Date
- POAI 11-11-2025
- EVAX 10-30-2025
- Dividend Yield
- POAI N/A
- EVAX N/A
- EPS Growth
- POAI N/A
- EVAX N/A
- EPS
- POAI N/A
- EVAX N/A
- Revenue
- POAI $1,664,696.00
- EVAX $3,176,000.00
- Revenue This Year
- POAI $486.27
- EVAX N/A
- Revenue Next Year
- POAI $65.50
- EVAX N/A
- P/E Ratio
- POAI N/A
- EVAX N/A
- Revenue Growth
- POAI 71.65
- EVAX 1042.45
- 52 Week Low
- POAI $0.55
- EVAX $1.20
- 52 Week High
- POAI $3.06
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- POAI 55.05
- EVAX 50.88
- Support Level
- POAI $0.90
- EVAX $2.71
- Resistance Level
- POAI $1.08
- EVAX $3.04
- Average True Range (ATR)
- POAI 0.07
- EVAX 0.20
- MACD
- POAI 0.00
- EVAX -0.01
- Stochastic Oscillator
- POAI 36.09
- EVAX 55.97
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.